Advertisement

Topics

Janssen inks deal with Genmab on follow-on to Darzalex

05:58 EDT 13 Jun 2019 | SmartBrief

Johnson & Johnson's Janssen Biotech and Genmab agreed to collaborate to develop and market a next-generation follow-on to Dar -More

Original Article: Janssen inks deal with Genmab on follow-on to Darzalex

NEXT ARTICLE

More From BioPortfolio on "Janssen inks deal with Genmab on follow-on to Darzalex"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...